Background: Angiotensin-converting enzyme (ACE) inhibitors are commonly used in clinical practice to treat hypertension. Hyperkalemia develops in approximately 10% of outpatients within a year of prescription of these drugs.
Aim and Objective: The aim of this study was to identify the prevalence of hyperkalemia among outpatients who are taking ACE inhibitors for hypertension for more than 6 months.
Materials and Methods: This was a cross-sectional study conducted in the Hypertension Clinic, Tirunelveli Medical College. Around 152 hypertensive patients taking ACE inhibitors for more than 6 months were enrolled in the study. Blood samples were obtained, and their serum potassium levels were measured.
Results: Among 152 patients, there were 88 male patients (57.9%) and 64 female patients (42.1%). Ten patients (35.71%) out of 18 patients who were on monotherapy presented with hyperkalemia and 20 patients (16.12%) out of 104 patients who were on combination therapy had hyperkalemia. A higher number of patients with hyperkalemia falls in the age group of 46–60 years of age. Out of 152 patients who took enalapril, 30 patients (19.73%) were found to have hyperkalemia. Of them, 20 patients (13.15%) had mild hyperkalemia, and ten patients (6.57%) had moderate hyperkalemia. There were no cases of severe hyperkalemia.
Conclusion: Hence, it is of considerable importance for physicians to identify patients at risk by regular monitoring and to implement measures to lessen the likelihood of the development of hyperkalemia.
Hyperkalemia; Hypertension; Angiotensin-converting enzyme inhibitors
Synthetic Strategies for FRET-Enabled Carbohydrate Active Enzyme Probes.
Singh M, Watkinson M, Scanlan EM, Miller GJ
Methods in molecular biology (Clifton, N.J.). 2022; 2370(): 237-264
Biochemical and Biological Assays of Mycolactone-Mediated Inhibition of Sec61.
O'Keefe S, High S, Demangel C
Methods in molecular biology (Clifton, N.J.). 2022; 2387(): 163-181
Hydrogel Formation with Enzyme-Responsive Cyclic Peptides.
Carlini AS, Cassidy MF, Gianneschi NC
Methods in molecular biology (Clifton, N.J.). 2022; 2371(): 427-448
Binding Characterization of Cyclic PeptideÂ Ligands to Target Proteins and Chemical Epitopes Using ELISA and Fluorescence Polarization Assays.
Borges A, Onasenko I, Nag A
Methods in molecular biology (Clifton, N.J.). 2022; 2371(): 335-354
Cryo-self-assembled silk fibroin sponge as a biodegradable platform for enzyme-responsive delivery of exosomes.
Sun M, Li Q, Yu H, Cheng J, Wu N, Shi W, Zhao F, Shao Z, Meng Q, Chen H, Hu X, Ao Y
Bioactive materials. 2022; 8(): 505-514